Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.

× No keyword cloud information.

10 in total

1. Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.

Authors: M Barza; J Brusch; M G Bergeron; L Weinstein
Journal: J Infect Dis Date: 1974-01 Impact factor: 5.226

2. Postantibiotic suppression of bacterial growth.

Authors: R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal: Rev Infect Dis Date: 1981 Jan-Feb

3. [Experimental study of optimal dose interval in antibiotic therapy].

Authors: A U Gerber; W A Craig
Journal: Schweiz Med Wochenschr Date: 1982-01-09

Review 4. Antibiotic assays in muscle: are conventional tissue levels misleading as indicator of the antibacterial activity?

Authors: D M Ryan; O Cars
Journal: Scand J Infect Dis Date: 1980

Review 5. Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo.

Authors: M G Bergeron; D Beauchamp; A Poirier; A Bastille
Journal: Rev Infect Dis Date: 1981 Jan-Feb

Review 6. Penetration of antibiotics into respiratory secretions.

Authors: J E Pennington
Journal: Rev Infect Dis Date: 1981 Jan-Feb

7. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.

Authors: A U Gerber; W A Craig; H P Brugger; C Feller; A P Vastola; J Brandel
Journal: J Infect Dis Date: 1983-05 Impact factor: 5.226

8. Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.

Authors: A U Gerber; W A Craig
Journal: J Lab Clin Med Date: 1982-11

9. Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.

Authors: A U Gerber; A P Vastola; J Brandel; W A Craig
Journal: J Infect Dis Date: 1982-11 Impact factor: 5.226

10. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.

Authors: S H Powell; W L Thompson; M A Luthe; R C Stern; D A Grossniklaus; D D Bloxham; D L Groden; M R Jacobs; A O DiScenna; H A Cash; J D Klinger
Journal: J Infect Dis Date: 1983-05 Impact factor: 5.226

10 in total

7 in total

7. Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model.

Authors: A U Gerber; S Kozak; C Segessenmann; U Flückiger; T Bangerter; U Greter
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-03 Impact factor: 3.267

7 in total

Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.

1. Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.

2. Postantibiotic suppression of bacterial growth.

3. [Experimental study of optimal dose interval in antibiotic therapy].

Review 4. Antibiotic assays in muscle: are conventional tissue levels misleading as indicator of the antibacterial activity?

Review 5. Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo.

Review 6. Penetration of antibiotics into respiratory secretions.

7. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.

8. Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.

9. Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.

10. Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.

Review 1. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC.

Review 2. Continuous infusion of beta-lactam antibiotics.

3. In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.

4. Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model.

5. Pharmacokinetics of intravenous antibiotics in acutely ill elderly patients.

Review 6. Clinical pharmacokinetics of cefotetan.

7. Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model.